HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melina Verso Selected Research

Nadroparin (Nadroparin Calcium)

10/2011Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.
4/2010Thromboprophylaxis during chemotherapy in patients with advanced cancer.
10/2009Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Melina Verso Research Topics

Disease

29Neoplasms (Cancer)
02/2022 - 10/2003
15Hemorrhage
02/2022 - 02/2008
12Venous Thromboembolism
01/2022 - 10/2003
8Venous Thrombosis (Deep-Vein Thrombosis)
01/2020 - 10/2003
5Thrombosis (Thrombus)
02/2022 - 04/2006
5Atrial Fibrillation
04/2019 - 09/2016
4Pulmonary Embolism
01/2020 - 06/2005
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020 - 01/2020
2Ischemic Stroke
04/2019 - 04/2019
1Body Weight (Weight, Body)
01/2020
1Embolism (Embolus)
04/2019
1Stroke (Strokes)
09/2016
1Neoplasm Metastasis (Metastasis)
05/2012
1Lung Neoplasms (Lung Cancer)
05/2012
1Multiple Myeloma
05/2012
1Thromboembolism
10/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2004
1Thrombocytopenia (Thrombopenia)
04/2004

Drug/Important Bio-Agent (IBA)

17AnticoagulantsIBA
02/2022 - 04/2006
5Dalteparin (Dalteparin Sodium)FDA Link
01/2022 - 09/2018
5Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2020 - 10/2009
4apixabanIBA
01/2022 - 09/2018
3Pharmaceutical PreparationsIBA
01/2020 - 06/2005
3RivaroxabanIBA
01/2020 - 01/2020
3edoxabanIBA
01/2020 - 01/2020
3Heparin (Liquaemin)FDA LinkGeneric
09/2012 - 04/2004
3Nadroparin (Nadroparin Calcium)IBA
10/2011 - 10/2009
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 05/2014
2Vitamin KFDA Link
01/2018 - 09/2016
2Fibrinolytic Agents (Antithrombotic Agents)IBA
04/2012 - 04/2006
2Enoxaparin (Lovenox)FDA LinkGeneric
06/2008 - 06/2005
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021
1Cytochrome P-450 CYP3AIBA
01/2021
1idarucizumabIBA
11/2017
1DabigatranFDA Link
11/2017
1Thalidomide (Thalomid)FDA Link
05/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2012
1Lenalidomide (CC 5013)FDA Link
05/2012
1ThrombinFDA Link
04/2012
1Factor Xa (Coagulation Factor Xa)IBA
04/2012
1TESIBA
10/2011

Therapy/Procedure

12Drug Therapy (Chemotherapy)
02/2022 - 10/2003
7Therapeutics
01/2020 - 04/2006
5Catheters
02/2022 - 06/2005
4Central Venous Catheters
05/2012 - 10/2003
2Radiotherapy
05/2012 - 06/2008
2Subcutaneous Injections
10/2011 - 10/2009
1Length of Stay
05/2014
1Contraindications
05/2012
1Vena Cava Filters (Inferior Vena Cava Filter)
02/2008
1Parenteral Nutrition
10/2003